Results 11 to 20 of about 9,019 (165)

Local staging of de novo prostate cancer using mpMRI, PSMA-PET and PSMA-PET/mpMRI – a comparative study

EJNMMI Research
Background Accurate diagnosis and staging are essential for optimal treatment planning of prostate cancer. By combining functional and anatomical imaging, PSMA-PET/mpMRI offers a potential to improve lesion detection and enhance staging accuracy.
Josefine Grefve, Sara N. Strandberg, Joakim Jonsson, Angsana Keeratijarut Lindberg, Erik Nilsson, Anders Bergh, Karin Söderkvist, Camilla Thellenberg Karlsson, Lennart Nedar, Vibeke Berg Løgager, Erik Thimansson, Elin Trägårdh, Johan Bengtsson, Erland Hvittfeldt, Jan Axelsson, Tufve Nyholm, Katrine Riklund, Kristina Sandgren   +17 more
doaj   +2 more sources

Intraoperative 3D-US-mpMRI Elastic Fusion Imaging-Guided Robotic Radical Prostatectomy: A Pilot Study [PDF]

Current Oncology, 2022
Introduction: When performing a nerve-sparing (NS) robotic radical prostatectomy (RARP), cancer location based on multiparametric MRI (mpMRI) is essential, as well as the location of positive biopsy cores outside mpMRI targets.
Marco Oderda, Giorgio Calleris, Daniele D’Agate, Marco Falcone, Riccardo Faletti, Marco Gatti, Giancarlo Marra, Alessandro Marquis, Paolo Gontero   +8 more
doaj   +2 more sources

Comparing Micro-Ultrasound to mpMRI in Detecting Clinically Significant Prostate Cancer

Société Internationale d’Urologie Journal, 2022
Objectives: To compare the performance of micro-ultrasound (mUS) with multi-parametric magnetic resonance imaging (mpMRI) in detecting clinically significant prostate cancer.
Christian Pavlovich, Laurence Klotz
doaj   +1 more source

Prostate cancer undetected by mpMRI: tumor conspicuity is reliant upon optimal scan timing and quality [PDF]

, 2021
We commend Alanee et al for their detailed description of prostate cancers not detected by multiparametric magnetic resonance imaging (mpMRI). 1 They analyzed radical prostatectomy findings for 33 men lacking mpMRI-conspicuous prostate cancer (defined as
Stavrinides, Vasilis, Whitaker, Hayley C., Giganti, Francesco, Kelly, Daniel, Kirkham, Alex, Freeman, Alex, Simpson, Benjamin S., Emberton, Mark, Allen, Clare, Norris, Joseph M., Ball, Rhys   +10 more
core   +1 more source

Semi-automated PIRADS scoring via mpMRI analysis [PDF]

, 2020
Purpose: Prostate cancer (PCa) is the most common solid organ cancer and second leading cause of death in men. Multiparametric magnetic resonance imaging (mpMRI) enables detection of the most aggressive, clinically significant PCa (csPCa) tumors that ...
Speier, William, Arnold, Corey W, Raman, Alex, Raman, Steven S, Marks, Leonard S, Sarma, Karthik V, Dhinagar, Nikhil J, Kinnaird, Adam   +7 more
core   +1 more source

Comparison between biparametric and multiparametric MR imaging of Prostate Imaging Reporting and Data System Version 2.1 in detection of prostate cancer

The Egyptian Journal of Radiology and Nuclear Medicine, 2021
Background Prostate cancer (PCa) is considered to be the commonest cancer among males. Early and precise diagnosis of PCa is essential for adequate treatment.
Mohamed Ali EL-Adalany, Ahmed Abd E L-khalek Abd EL-Razek, Tarek EL-Diasty, Ahmed EL-Hendy, Dina EL-Metwally   +4 more
doaj   +1 more source

Which Prostate Cancers are Undetected by Multiparametric Magnetic Resonance Imaging in Men with Previous Prostate Biopsy? An Analysis from the PICTURE Study

European Urology Open Science, 2021
Background: Multiparametric magnetic resonance imaging (mpMRI) has improved risk stratification for suspected prostate cancer in patients following prior biopsy. However, not all significant cancers are detected by mpMRI.
Joseph M. Norris, Lucy A.M. Simmons, Abi Kanthabalan, Alex Freeman, Neil McCartan, Caroline M. Moore, Shonit Punwani, Hayley C. Whitaker, Mark Emberton, Hashim U. Ahmed   +9 more
doaj   +1 more source

Genetic correlates of prostate cancer visibility (and invisibility) on mpMRI: It's time to take stock [PDF]

, 2020
Multiparametric magnetic resonance imaging (mpMRI) has enhanced risk stratification for men at risk of prostate cancer, through accurate pre‐biopsy detection of high‐risk disease.
Whitaker, Hayley C., Benjamin S. Simpson, Daniel Kelly, Whitaker, HC, Veeru Kasivisvanathan, Kirkham, Alex, Parry, Marina A., Parry, MA, Emberton, M, Rhys Ball, Hayley C. Whitaker, Ball, R, Emberton, Mark, Kasivisvanathan, V, Kasivisvanathan, Veeru, Kelly, Daniel, Kirkham, A, Marina A. Parry, Alex Freeman, Norris, JM, Allen, Clare, Kelly, D, Clare Allen, Joseph M. Norris, Mark Emberton, Alex Kirkham, Simpson, BS, Freeman, A, Simpson, Benjamin S., Freeman, Alex, Allen, C, Norris, Joseph M., Ball, Rhys   +32 more
core   +2 more sources

Assessment of DCE Utility for PCa Diagnosis Using PI-RADS v2.1: Effects on Diagnostic Accuracy and Reproducibility

Diagnostics, 2020
The role of dynamic contrast-enhanced-MRI (DCE-MRI) for Prostate Imaging-Reporting and Data System (PI-RADS) scoring is a controversial topic. In this retrospective study, we aimed to measure the added value of DCE-MRI in combination with T2-weighted ...
Valentina Brancato, Giuseppe Di Costanzo, Luca Basso, Liberatore Tramontano, Marta Puglia, Alfonso Ragozzino, Carlo Cavaliere   +6 more
doaj   +1 more source

Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRI

Clinical and Translational Radiation Oncology, 2022
Purpose: Our purpose was to evaluate intra-prostatic cancer volumes for salvage radiotherapy in men with recurrent prostate cancer confined to the prostate post-primary radiotherapy using mpMRI and 18F-DCFPyL PET/CT (PET).
Wei Liu, Hatim Fakir, Gurpreet Randhawa, Ryan Alfano, Mark Corkum, Zahra Kassam, Irina Rachinsky, Hans T. Chung, Peter Chung, Andrew Loblaw, Gerard Morton, Tracy Sexton, Anil Kapoor, Aaron Ward, Katherine Zukotynski, Louise Emmett, Glenn Bauman   +16 more
doaj   +1 more source